Medulloblastoma Sensitivity to 17-Allylamino-17-demethoxygeldanamycin Requires MEK/ERK

This publication has 43 references indexed in Scilit:

• Signal Transduction–Directed Cancer Treatments
  Annual Review of Pharmacology and Toxicology, 2003
• The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
  Leukemia, 2002
• Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
  Oncogene, 2002
• Anticancer therapy targeting the erbB family of receptor tyrosine kinases
  Seminars in Oncology, 2001
• Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
  Oncogene, 2001
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
  Journal of Biological Chemistry, 2000
• Geldanamycin-Induced Destabilization of Raf-1 Involves the Proteasome
  Biochemical and Biophysical Research Communications, 1997
• Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo
  Oncogene, 1997
• The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase
  Journal of Biological Chemistry, 1997